trial

Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental Illness

NCTId NCT06641726
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Recruiting
Enrollment 50,000 (estimated)
Sponsored by Akrivia Health
Primary completion 2035-01-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
50,000 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2025-05-16
Primary completion
2035-01-01
Eligibility
ALL · 18 Years · 110 Years

Interventions & indications

Drugs
Not applicable- observational study

Sponsors

Akrivia HealthLead Sponsor
Cardiff UniversityCollaborator

Investigators

1
Prof. James WaltersPrincipal Investigator

Sites

1 total
Oxford, United Kingdom

Facts & assertions

4 sourced
Enrollment
50,000
Phase
NA
Primary Completion Date
2035-01-01
Status
RECRUITING
relationships
The graph out of here
drug
Not applicable- observational study
drug
lead_sponsor
Akrivia Health
company
collaborator
Cardiff University
company
indication
Bipolar Disorder
indication
Dementia
indication
Dementia
indication
investigator
Prof. James Walters
person